BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Wall Street rises with investors rotating into healthcare and value stocks
- Brent slips as Iran president discusses mediation with Pakistan army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
| (NASDAQ: BNTX) | Delayed: 90.18 +0.97 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.21 | 52 Week High | $ | |||
| Open | $89.50 | 52 Week Low | $ | |||
| Day High | $90.29 | P/E | N/A | |||
| Day Low | $88.57 | EPS | $ | |||
| Volume | 1,107,803 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 241.24 +14.35 (6.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $226.89 | 52 Week High | $0.52 | |||
| Open | $226.03 | 52 Week Low | $0.08 | |||
| Day High | $243.00 | P/E | N/A | |||
| Day Low | $216.65 | EPS | $-3.80 | |||
| Volume | 12,469,656 | |||||
